Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Florbetaben PET in Subjects with Subjective Cognitive Decline
2016-003451-30Phase 2Terminated
- Sponsor
- August Pi i Sunyer Biomedical Research Institute
- Start
- Dec 2016
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flutemetamol, sponsored by August Pi i Sunyer Biomedical Research Institute. Started Dec 2016; status: terminated.
02
Drugs
flutemetamol
Beyond the preview
Go deeper on 2016-003451-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003451-30.